{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T02:00:30Z","timestamp":1760061630634,"version":"3.38.0"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,1,15]]},"DOI":"10.2146\/ajhp110287","type":"journal-article","created":{"date-parts":[[2012,1,4]],"date-time":"2012-01-04T00:36:11Z","timestamp":1325637371000},"page":"134-142","source":"Crossref","is-referenced-by-count":9,"title":["Pharmacokinetics of tacrolimus and mycophenolate mofetil in renal transplant recipients on a corticosteroid-free regimen"],"prefix":"10.1093","volume":"69","author":[{"given":"Erica D.","family":"Greanya","sequence":"first","affiliation":[{"name":"Vancouver Coastal Health Authority, Vancouver, Canada, and Clinical Assistant Professor, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Poulin","sequence":"additional","affiliation":[{"name":"Nesters Market Pharmacy, Whistler, Canada."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nilufar","family":"Partovi","sequence":"additional","affiliation":[{"name":"Vancouver Coastal Health Authority, and Clinical Professor, Faculty of Pharmaceutical Sciences, University of British Columbia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Jean","family":"Shapiro","sequence":"additional","affiliation":[{"name":"Solid Organ Transplantation, Vancouver General Hospital, Vancouver, and Clinical Associate Professor, Faculty of Medicine, University of British Columbia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mai","family":"Al-Khatib","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, University of British Columbia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary H. H.","family":"Ensom","sequence":"additional","affiliation":[{"name":"Doctor of Pharmacy Program, Faculty of Pharmaceutical Sciences, and Distinguished University Scholar, University of British Columbia, and Clinical Pharmacy Specialist, Department of Pharmacy, Children\u2019s and Women\u2019s Health Centre of British Columbia, Vancouver"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"issue":"(suppl 3)","key":"2019041606595737200_b1-0690134","first-page":"S1","article-title":"KDIGO clinical practice guideline for the care of kidney transplant recipients","volume":"9","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group","year":"2009","journal-title":"Am J Transplant"},{"issue":"(suppl 2)","key":"2019041606595737200_b2-0690134","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1053\/j.ajkd.2005.12.047","article-title":"Current and evolving immunosuppressive regimens in kidney transplantation","volume":"47","author":"Gaston","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"2019041606595737200_b3-0690134","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1600-6143.2007.02057.x","article-title":"A randomized, multicenter study of steroid avoidance, early steroid withdrawal or standard steroid therapy in kidney transplant recipients","volume":"8","author":"Vincenti","year":"2008","journal-title":"Am J Transplant"},{"key":"2019041606595737200_b4-0690134","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/SLA.0b013e318187d1da","article-title":"A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy","volume":"248","author":"Woodle","year":"2008","journal-title":"Ann Surg"},{"key":"2019041606595737200_b5-0690134","doi-asserted-by":"crossref","first-page":"623","DOI":"10.2165\/00003088-200443100-00001","article-title":"Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation","volume":"43","author":"Staatz","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"2019041606595737200_b6-0690134","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/00007890-200105150-00021","article-title":"The effect of gut metabolism on tacrolimus bioavailability in renal transplant recipients","volume":"71","author":"Tuteja","year":"2001","journal-title":"Transplantation"},{"key":"2019041606595737200_b7-0690134","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0090-9556(24)15298-1","article-title":"The disposition of 14C-labeled tacrolimus after intravenous and oral administration in healthy human subjects","volume":"27","author":"M\u00f6ller","year":"1999","journal-title":"Drug Metab Dispos"},{"key":"2019041606595737200_b8-0690134","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2165\/00003088-200746010-00002","article-title":"Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients","volume":"46","author":"Staatz","year":"2007","journal-title":"Clin Pharmacokinet"},{"key":"2019041606595737200_b9-0690134","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1046\/j.0306-5251.2001.01487.x","article-title":"The glucuronidation of mycophenolic acid by human liver, kidney and jejunum microsomes","volume":"52","author":"Bowalgaha","year":"2001","journal-title":"Br J Clin Pharmacol"},{"key":"2019041606595737200_b10-0690134","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/sj.bjp.0703898","article-title":"Glucuronide and glucoside conjugation of mycophenolic acid by human liver, kidney and intestinal microsomes","volume":"132","author":"Shipkova","year":"2001","journal-title":"Br J Pharmacol"},{"key":"2019041606595737200_b11-0690134","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2165\/00003088-199834060-00002","article-title":"Clinical pharmacokinetics of mycophenolate mofetil","volume":"34","author":"Bullingham","year":"1998","journal-title":"Clin Pharmacokinet"},{"key":"2019041606595737200_b12-0690134","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.clpt.2005.06.008","article-title":"Genetic and nongenetic determinants of between-patient variability in the pharmacokinetics of mycophenolic acid","volume":"78","author":"Hesselink","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"2019041606595737200_b13-0690134","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1592\/phco.30.11.1097","article-title":"Pharmacogenetic impact of UDP-glucuronosyltransferase metabolic pathway and multidrug resistance- associated protein 2 transport pathway on mycophenolic acid in thoracic transplant recipients: an exploratory study","volume":"30","author":"Ting","year":"2010","journal-title":"Pharmacotherapy"},{"key":"2019041606595737200_b14-0690134","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1472-8206.2008.00644.x","article-title":"Tacrolimus pharmacokinetic drug interactions: effect of prednisone, mycophenolic acid or sirolimus","volume":"23","author":"Park","year":"2009","journal-title":"Fundam Clin Pharmacol"},{"key":"2019041606595737200_b15-0690134","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1345\/aph.1K628","article-title":"Corticosteroid interactions with cyclosporine, tacrolimus, mycophenolate and sirolimus: fact or fiction?","volume":"42","author":"Lam","year":"2008","journal-title":"Ann Pharmacother"},{"key":"2019041606595737200_b16-0690134","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1093\/ndt\/17.11.2036","article-title":"MDRD equation estimates of glomerular filtration rate in potential living kidney donors and renal transplant recipients with impaired graft function","volume":"17","author":"Stoves","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"2019041606595737200_b17-0690134","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/clinchem\/42.2.279","article-title":"Sensitive, specific quantitative analysis of tacrolimus (FK506) in blood by liquid chromatography-electrospray tandem mass spectrometry","volume":"42","author":"Taylor","year":"1996","journal-title":"Clin Chem"},{"key":"2019041606595737200_b18-0690134","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1345\/aph.1H149","article-title":"Pharmacokinetics of mycophenolic acid and its glucuronidated metabolites in stable lung transplant recipients","volume":"40","author":"Ting","year":"2006","journal-title":"Ann Pharmacother"},{"key":"2019041606595737200_b19-0690134","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/FTD.0b013e318166eba0","article-title":"Pharmacokinetics of mycophenolic acid and its phenolic-glucuronide and ACYl glucuronide metabolites in stable thoracic transplant recipients","volume":"30","author":"Ting","year":"2008","journal-title":"Ther Drug Monit"},{"key":"2019041606595737200_b20-0690134","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/01.ftd.0000255011.75863.15","article-title":"Effect of acidification on protein binding of mycophenolic acid","volume":"29","author":"Ting","year":"2007","journal-title":"Ther Drug Monit"},{"key":"2019041606595737200_b21-0690134","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1067\/mcp.2002.129304","article-title":"Population pharmacokinetics of tacrolimus in adult kidney transplant recipients","volume":"72","author":"Staatz","year":"2002","journal-title":"Clin Pharmacol Ther"},{"key":"2019041606595737200_b22-0690134","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1177\/0091270003254797","article-title":"Chronopharmacokinetics of tacrolimus in kidney transplant recipients: occurrence of acute rejection","volume":"43","author":"Tada","year":"2003","journal-title":"J Clin Pharmacol"},{"key":"2019041606595737200_b23-0690134","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2165\/00003088-200443110-00005","article-title":"Time-related clinical determinants of long-term tacrolimus pharmacokinetics in combination therapy with mycophenolic acid and corticosteroids: a prospective study in one hundred de novo renal transplant recipients","volume":"43","author":"Kuypers","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"2019041606595737200_b24-0690134","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1111\/j.1523-1755.2005.00352.x","article-title":"AUC-guided dosing of tacrolimus prevents progressive systemic overexposure in renal transplant recipients","volume":"67","author":"Scholten","year":"2005","journal-title":"Kidney Int"},{"key":"2019041606595737200_b25-0690134","first-page":"242","article-title":"New immunosuppressive agents for maintenance therapy in organ transplantation: focus on adverse effects","volume":"16","author":"Mor","year":"1997","journal-title":"BioDrugs"},{"key":"2019041606595737200_b26-0690134","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1034\/j.1399-0012.1999.130301.x","article-title":"Cyclosporine and tacrolimus (FK506): a comparison of efficacy and safety profiles","volume":"13","author":"Henry","year":"1999","journal-title":"Clin Transplant"},{"key":"2019041606595737200_b27-0690134","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0041-1345(00)02142-4","article-title":"Experimental study of tacrolimus immunosuppression on the mode of administration: efficacy of constant intravenous infusion avoiding C(max)","volume":"33","author":"Ishibashi","year":"2001","journal-title":"Transplant Proc"},{"key":"2019041606595737200_b28-0690134","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.transproceed.2010.03.123","article-title":"Once daily tacrolimus formulation: monitoring of plasma levels, graft function, and cardiovascular risk factors","volume":"42","author":"Me\u00e7ule","year":"2010","journal-title":"Transplant Proc"},{"key":"2019041606595737200_b29-0690134","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/00007691-200002000-00003","article-title":"Pharmacokinetics and concentration-control investigations of mycophenolic acid in adults after transplantation","volume":"22","author":"Shaw","year":"2000","journal-title":"Ther Drug Monit"},{"key":"2019041606595737200_b30-0690134","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/00007691-199910000-00008","article-title":"Drug interaction between mycophenolate mofetil and tacrolimus detectable within therapeutic mycophenolic acid monitoring in renal transplant patients","volume":"21","author":"H\u00fcbner","year":"1999","journal-title":"Ther Drug Monit"},{"key":"2019041606595737200_b31-0690134","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0966-3274(97)80042-1","article-title":"Unexpected augmentation of mycophenolic acid pharmacokinetics in renal transplant patients receiving tacrolimus and mycophenolate mofetil in combination therapy, and analogous in vitro findings","volume":"5","author":"Zucker","year":"1997","journal-title":"Transpl Immunol"},{"key":"2019041606595737200_b32-0690134","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00007691-199902000-00006","article-title":"Evidence that tacrolimus augments the bioavailability of mycophenolate mofetil through inhibition of mycophenolic acid glucuronidation","volume":"21","author":"Zucker","year":"1999","journal-title":"Ther Drug Monit"},{"key":"2019041606595737200_b33-0690134","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1177\/0091270004270145","article-title":"Intra-individual and interindividual variations in the pharmacokinetics of mycophenolic acid in liver transplant recipients","volume":"45","author":"Pisupati","year":"2005","journal-title":"J Clin Pharmacol"},{"key":"2019041606595737200_b34-0690134","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1345\/aph.1D099","article-title":"Mycophenolate pharmacokinetics in early period following lung or heart transplantation","volume":"37","author":"Ensom","year":"2003","journal-title":"Ann Pharmacother"},{"key":"2019041606595737200_b35-0690134","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1681\/ASN.V981511","article-title":"Pharmacokinetics of mycophenolic acid (MPA) and determinants of MPA free fraction in pediatric and adult renal transplant recipients","volume":"9","author":"Weber","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"2019041606595737200_b36-0690134","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/FTD.0b013e3181d80c1b","article-title":"Pharmacokinetics of mycophenolic acid and its glucuronidated metabolites in stable islet transplant recipients","volume":"32","author":"Al-Khatib","year":"2010","journal-title":"Ther Drug Monit"},{"key":"2019041606595737200_b37-0690134","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1177\/00912700122010087","article-title":"Pharmacokinetics of mycophenolic acid after mycophenolate mofetil administration in liver transplant patients treated with tacrolimus","volume":"41","author":"Jain","year":"2001","journal-title":"J Clin Pharmacol"},{"key":"2019041606595737200_b38-0690134","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/00007691-200310000-00011","article-title":"Twelve-month evaluation of the clinical pharmacokinetics of total and free mycophenolic acid and its glucuronide metabolites in renal allograft recipients on low dose tacrolimus in combination with mycophenolate mofetil","volume":"25","author":"Kuypers","year":"2003","journal-title":"Ther Drug Monit"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/69\/2\/134\/28455120\/ajhp0134.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T14:46:06Z","timestamp":1742222766000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/69\/2\/134\/5112005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,15]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,1,15]]}},"URL":"https:\/\/doi.org\/10.2146\/ajhp110287","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"type":"print","value":"1079-2082"},{"type":"electronic","value":"1535-2900"}],"subject":[],"published-other":{"date-parts":[[2012,1,15]]},"published":{"date-parts":[[2012,1,15]]}}}